G1 Therapeutics Q4 EPS $(0.73) Beats $(0.84) Estimate, Sales $10.30M Beat $9.65M Estimate
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.84) by 13.1 percent. This is a 22.34 percent increase over losses of $(0.94) per share from